{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:14:47Z","timestamp":1789848887210,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.ygyno.2008.11.003","type":"journal-article","created":{"date-parts":[[2008,12,7]],"date-time":"2008-12-07T05:20:53Z","timestamp":1228627253000},"page":"353-357","source":"Crossref","is-referenced-by-count":46,"title":["Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia"],"prefix":"10.1016","volume":"112","author":[{"given":"Whitfield B.","family":"Growdon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Wolfberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Feltmate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel E.","family":"Chinchilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellice S.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross S.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.11.003_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00003081-200309000-00006","article-title":"Gestational trophoblastic disease epidemiology and trends","volume":"46","author":"Smith","year":"2003","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib2","first-page":"445","article-title":"Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report","volume":"47","author":"Kohorn","year":"2002","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.11.003_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.AOG.0000136099.21216.45","article-title":"Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy","volume":"104","author":"Wolfberg","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib4","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199612053352306","article-title":"Chorionic tumors","volume":"335","author":"Berkowitz","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2008.11.003_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/gyno.1993.1028","article-title":"Development of postmolar trophoblastic disease after partial molar pregnancy","volume":"48","author":"Goto","year":"1993","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib6","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(90)92641-T","article-title":"Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole","volume":"335","author":"Bagshawe","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2008.11.003_bib7","first-page":"902","article-title":"Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy","volume":"51","author":"Feltmate","year":"2006","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.11.003_bib8","first-page":"764","article-title":"Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome","volume":"51","author":"Hancock","year":"2006","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.11.003_bib9","first-page":"219","article-title":"Management of nonmetastatic trophoblastic tumors","volume":"26","author":"Berkowitz","year":"1981","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.11.003_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.AOG.0000224697.31138.a1","article-title":"Gestational trophoblastic disease","volume":"108","author":"Soper","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib11","first-page":"354","article-title":"Gestational trophoblastic disease: treatment results at the brewer trophoblastic disease center","volume":"60","author":"Lurain","year":"1982","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib12","first-page":"49","article-title":"Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use","volume":"36","author":"Kohorn","year":"1991","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.11.003_bib13","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.2002.07.166","article-title":"Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000","volume":"20","author":"McNeish","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0002-9378(95)90575-8","article-title":"Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors","volume":"172","author":"Lurain","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib15","first-page":"355","article-title":"ethotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15\u00a0years of experience","volume":"47","author":"Garrett","year":"2002","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.11.003_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/gyno.1994.1169","article-title":"5-day methotrexate for women with metastatic gestational trophoblastic disease","volume":"54","author":"Soper","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0090-8258(86)90123-X","article-title":"Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease","volume":"23","author":"Berkowitz","year":"1986","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib18","first-page":"725","article-title":"Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms","volume":"54","author":"Berkowitz","year":"1979","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ygyno.2004.11.011","article-title":"Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy","volume":"96","author":"Matsui","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib20","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1067\/mob.2000.108077","article-title":"Methotrexate infusion in low-risk gestational trophoblastic disease","volume":"183","author":"Wong","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib21","first-page":"871","article-title":"Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies","volume":"51","author":"Growdon","year":"2006","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.11.003_bib22","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.AOG.0000174583.51617.25","article-title":"Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy","volume":"106","author":"Wolfberg","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.2005.03.3043","article-title":"Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease","volume":"24","author":"van Trommel","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ygyno.2004.10.022","article-title":"The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease","volume":"95","author":"Goldstein","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2005.06.032","article-title":"The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey","volume":"99","author":"van Trommel","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2004.08.045","article-title":"The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease","volume":"95","author":"Pezeshki","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib27","first-page":"602","article-title":"What is the best regimen for low-risk gestational trophoblastic neoplasia? A review","volume":"49","author":"Osborne","year":"2004","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2008.11.003_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/AOG.0b013e31817f58ae","article-title":"Gestational trophoblastic neoplasia: treatment outcomes","volume":"112","author":"Hoekstra","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.11.003_bib29","first-page":"S1","article-title":"A randomized phase III trial comparing weekly parenteral methotrexate and \u201cpulsed\u201d dactinomycin as primary management for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study","volume":"108","author":"Osborne","year":"2008","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808009414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808009414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T16:25:15Z","timestamp":1545582315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808009414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0090825808009414"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.11.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}